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neuroendocrine Perspectives  
in Alopecia Areata:  
Does stress Play a Role?
Ralf Paus1,2 and Petra Arck3
Until recently, the popular notion that psychoemotional stress can have an 
impact on hair growth has been treated with skepticism and assigned to the 
realm of folklore by many authorities. Yet it has long been appreciated that epi-
sodes of alopecia areata (AA) have occurred after severely stressful life events 
(Reinhold, 1960; Whitlock, 1976). This has triggered debates about whether AA 
should be considered a psychosomatic disorder (Misery and Rousset, 2001; 
Willemsen et al., 2009).
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A convincing cause–effect relation-
ship has never been firmly established 
between perceived stress and AA onset, 
course, and/or severity. It is by no means 
trivial to reliably distinguish “stress” as 
a genuine disease trigger from disease-
induced distress that, retrospectively and 
erroneously, may be identified by affect-
ed individuals as the “cause” of their 
hair loss (Whitlock, 1976; Hadshiew et 
al., 2004). In fact, the concept that AA 
can be triggered by psychoemotional 
stress has been cast into doubt (van der 
Steen et al., 1992; Brajac et al., 2003). 
With the increasing evidence that AA is 
a T-cell-dependent, organ-specific auto-
immune disease, the genesis of which is 
a collapse of the hair follicle’s immune 
privilege (Paus et al., 2005, Gilhar et 
al., 2007), the “brain–skin connection” 
(Paus et al., 2006) has been neglected.
However, the fact remains that cases 
have been reported—albeit rarely—
in which psychoemotional stress has 
clearly preceded AA onset or relapse, 
perhaps most impressively in the form 
of alopecia à deux in a husband-and-
wife setting under conditions of shared 
emotional stress (Swift, 1961; Zalka et 
al., 1994). Moreover, striking abnor-
malities in peptidergic innervation of 
lesional hair follicles have been iden-
tified in AA (Hordinsky and Ericson, 
1996). The expression of receptors for 
a key neuroendocrine stress mediator, 
corticotropin-releasing hormone, and 
of another classic mediator along the 
hypothalamic–pituitary–adrenal (HPA) 
stress-response axis, adrenocorticotro-
pin, were reported to be upregulated in 
lesional hair follicles of small cohorts of 
patients (Katsarou-Katsari et al., 2001; 
Kim et al., 2006).
This ambiguous picture makes it 
inevitable that investigators will turn to 
animal models for help. Indeed, it was 
in mice that the first solid evidence was 
at long last generated that perceived 
stress could exert surprisingly profound 
hair growth–inhibitory effects, includ-
ing the premature induction of hair fol-
licle regression (catagen), probably as 
a consequence of perifollicular neuro-
genic inflammation (Arck et al., 2001, 
2003; Aoki et al., 2003; Katayama et al., 
2007). Subsequently, detailed work in 
mice has identified at least one plausible 
molecular stress-response pathway by 
which perceived stress can lead to hair 
growth inhibition, with key roles identi-
fied for nerve growth factor, substance P 
(SP) and the cognate receptors as central 
stress mediators, and mast cells as “cen-
tral switchboards” of stress-induced 
perifollicular neurogenic inflammation 
(Arck et al., 2005; Peters et al., 2006).
This body of work has established 
that psychoemotional stress can indeed 
negatively impact hair growth, at least 
in mice. What has not been resolved, 
however, are the following questions: 
(i) whether any of this is relevant for 
humans, (ii) whether perceived stress 
can also induce actual hair shaft shed-
ding, leading to visible alopecia, in 
mice, and (iii) whether stress can trigger 
or aggravate AA (in mice or in humans). 
The recent observations that both nerve 
growth factor and SP are potent hair 
growth inhibitors for human hair and 
that SP causes the major histocompat-
ibility complex class I–based immune 
privilege of the hair follicle to collapse 
(Peters et al., 2005, 2007) suggest that 
the stress studies for mice summarized 
above are relevant to humans as well. 
However, convincing experimental 
evidence that AA—or any form of vis-
ible hair loss, for that matter—can be 
triggered by perceived stress remains 
to be published.
It is in this area that the study by Zhang 
and co-workers (2009, this issue) attains 
special relevance and importance—not 
only by adding a long-overdue facet to 
our incomplete understanding of AA 
pathogenesis but also for its bearing on 
general stress research and cutaneous 
neuroendocrinology.
Given that psychoemotional 
contributions to AA in humans may be 
camouflaged by emotional responses to 
the hair loss itself, the authors elegantly 
aimed at teasing apart stress-response 
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pathways in the context of AA by turn-
ing to the murine system, using the best 
established and most widely studied 
animal model, AA C3H/HeJ mice (Sun 
et al., 2008). A key finding of the study 
by Zhang et al. (2009) is that these mice 
have a significantly blunted systemic 
HPA response to acute physiological 
stress, along with a defective adaptation 
to repeated psychological stress. Further, 
highly active central and peripheral 
HPA activity and defective interactions 
between the HPA and hypothalamic–
pituitary–gonadal endocrine axes were 
observed. Strikingly, HPA hormones, as 
well as cytokine expression in the skin, 
were modulated by perceived stress in 
these mice (Zhang et al., 2009).
When normal C3H/HeJ mice and 
those affected with skin graft–induced 
AA were subjected to light ether anes-
thesia (as a physiological stressor) or 
restraint stress (as a psychological stres-
sor), they displayed a marked increase 
in HPA tone and activity compared with 
control mice, not only centrally but 
also peripherally in the skin and lymph 
nodes. These observations underscore 
the now firmly established concept that 
murine and human skin and hair fol-
licles display fully functional peripheral 
equivalents of the central HPA axis (Ito et 
al., 2005; Slominski et al., 2004, 2007). 
Moreover, these mice had significantly 
blunted corticosterone and adrenocor-
ticotropin responses to the physiologi-
cal stressor and a deficit in habituation 
to repeated exposure to the employed 
psychological stressor. Finally, a positive 
correlation of HPA hormone levels with 
T helper 1 cytokine levels in the skin 
was observed. The authors conclude 
that altered HPA activity may occur as 
a consequence of the immune response 
associated with AA.
This elegant study in a well-defined 
mouse model of an AA-like disease 
clearly supports the concept that psy-
chological stress is an important factor to 
be reckoned with in individuals prone to 
develop AA. It nicely complements earli-
er work by Siebenhaar et al. (2007), who 
investigated the role of SP in AA mice. 
Those authors found that the number of 
intracutaneous SP-immunoreactive nerve 
fibers increased during early stages of AA 
development, associated with enhanced 
degranulation of perifollicular mast cells, 
followed by a decline in the number of 
SP-immunoreactive nerves and SP pro-
tein levels in advanced lesional skin. 
SP receptors (NK1) were expressed on 
CD8+ lymphocytes and macrophages 
that accumulated around affected hair 
follicles in AA. Moreover, Zhang et al. 
(2009) highlighted the level of complex-
ity of the brain–skin connection in health 
and disease that must be taken into con-
sideration, especially when hair follicles 
and stress responses are involved (Peters 
et al., 2006; Arck et al., 2006).
As the authors appropriately acknowl-
edge, their study does not yet answer the 
original question of whether psycho-
emotional stress can actually trigger AA. 
In fact, they hypothesize that the altered 
HPA activity seen in AA could well result 
from the chronic inflammatory events 
that characterize AA skin (Gilhar et al., 
2007; Sun et al., 2008). It is a reasonable 
hypothesis that endocrine and inflam-
matory events associated with AA, rath-
er than stress associated with the nega-
tive image perception triggered by the 
disease, may account for the aberrant 
psychosocial traits noted in some (but 
by no means the majority of) patients. It 
now remains to be determined whether 
and how the HPA axis participates in the 
onset of disease.
The C3H/HeJ mouse model pro-
vides a platform for testing therapeu-
tic intervention strategies in AA (Sun 
et al., 2008). Given the pivotal role of 
SP—in responses to stress as well as in 
AA—testing highly selective SP receptor 
antagonists in the context of AA may not 
only ameliorate AA but also dampen the 
highly active central and peripheral HPA 
activity seen in the disease, which may 
improve patients’ resistance to stress 
challenges.
The current study leaves open the 
intriguing and important question of 
the extent to which intracutaneously 
generated stress mediators (whose pro-
duction in AA-affected skin and subse-
quent release into the circulation may 
well be greatly enhanced) affect the 
central HPA axis and thus modulate sys-
temic immune responses by HPA axis–
associated mediators (Arck et al., 2009; 
Paus et al., 2006). This question notwith-
standing, Zhang et al. (2009) elegantly 
underscore how important it is to pursue 
systematically a neuroendocrinological 
and neuroimmunological perspective in 
inflammatory skin disease research.
Systematic exploitation of murine 
in vivo models (e.g., Arck et al., 2003; 
Aoki et al., 2003; Kaneko et al., 2003; 
Zhang et al., 2009) will promote our 
understanding of the underestimated 
and underinvestigated, but clinically 
important, intimate relationship among 
psychoemotional stress, intracutaneous 
neurogenic inflammation, and peripher-
al tissue stress responses. Analysis of the 
latter should include dissection of stress- 
and/or inflammation-associated changes 
in skin innervation and skin neurophysi-
ology, for example, following available 
guidelines (Hendrix et al., 2008). In 
addition, future studies on intracutane-
ous responses to perceived stress should 
include attempts to determine whether 
skin-derived neuroendocrine feedback 
signals can indeed affect the central ner-
vous system and the secretory activities 
of central endocrine organs.
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